CLINICAL_TRIALS
trial_result
· 2010-07-16
Clinical Trial Update: 40 Week Extension Study Of Asenapine and Olanzapine For Bipolar Disorder (A7501007)(COMPLETED)(P05857) [Phase 3]
Summary
Phase 3 40-week extension study of asenapine and olanzapine for bipolar disorder has completed with results posted in 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Organon and Co | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED | Results posted: 2010-07-16